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In order to survive in mixed microbial communities, some species of fungi
secrete coprogens, siderophores that facilitate capture of the scarce nutrient
iron. The TonB-dependent transporter FhuE is integrated in the outer
membrane of Gram-negative bacteria and has been reported to scavenge these
fungally produced coprogens. In this work, an Escherichia coli strain was
engineered that is dependent solely on FhuE for its access to siderophore-
sequestered iron. Using this tool, it is shown that while FhuE is highly active in
the import of coprogens, it has some level of promiscuity, acting as a low-affinity
transporter for related siderophores. The crystal structure of FhuE in complex
with coprogen was determined, providing a structural basis to explain this
selective promiscuity. The structural data, in combination with functional
analysis, presented in this work show that FhuE has evolved to specifically
engage with planar siderophores. A potential evolutionary driver, and a critical
consequence of this selectivity, is that it allows FhuE to exclude antibiotics that
mimic nonplanar hydroxamate siderophores: these toxic molecules could
otherwise cross the outer membrane barrier through a Trojan horse mechanism.
1. Introduction
The incredible diversity and abundance of microbial life leads
to fierce competition for resources in any given environment
(Hibbing et al., 2010; Fredrickson & Stephanopoulos, 1981). In
this battle for growth and survival, bacteria and fungi deploy a
myriad of strategies to kill or hinder their competitors and to
seize scarce nutrients required for growth (Ghoul & Mitri,
2016). One such nutrient is iron: while abundant on Earth,
iron is biologically scarce owing to its insolubility under
oxygenic conditions (Wandersman & Delepelaire, 2004). Iron
is an essential nutrient for microorganisms that is needed as a
cofactor in proteins responsible for electron transport (Cassat
& Skaar, 2013; Troxell et al., 2012). In order to obtain iron
from the environment, the vast majority of bacteria and fungi
secrete small molecules termed siderophores. Siderophores
are multidentate ligands that bind iron(III) with an exceed-
ingly high affinity, giving them the ability to capture and
coordinate iron in a highly stable complex (Guerinot, 1994).
This iron-loaded complex is then recaptured by the micro-
organism and processed to release the iron for use by the cell
(Ferguson & Deisenhofer, 2004). Siderophore recapture is
mediated by cell-surface membrane-transport proteins, which
have specificity for a single or a related group of siderophores
(Braun & Hantke, 2011; Schalk et al., 2012; Hickman et al.,
2017).
While the overall diversity of siderophore molecules is high,
with >260 chemically distinct siderophores described to date
(Johnstone & Nolan, 2015), the chemistry of iron-coordinating
functional groups is more constrained. Iron(III) is a hard acid
and favours interactions with the hard base oxygen (Renshaw
et al., 2002). As such, siderophore functional groups utilize O
atoms in a bidentate configuration for iron coordination
(Codd, 2008; Renshaw et al., 2002). The two most common
functional groups are the catecholate and hydroxamate
moieties [Fig. 1(a)], with the former being more commonly
produced by bacteria and the latter being more common in
siderophores of fungal origin (Johnstone & Nolan, 2015;
Codd, 2008).
The coprogens are a class of linear dihydroxamate or
trihydroxamate siderophores that are widely produced by
fungi (Hossain et al., 1987; Hesseltine et al., 1952). Dihy-
droxamate coprogens, such as rhodotorulic acid, are formed
by the head-to-head condensation of the nonproteinogenic
amino acid N-acetyl-N-hydroxy-l-ornithine, creating a 2,5-
diketopiperazine ring that typifies the family [Fig. 1(b);
Renshaw et al., 2002]. In trihydroxamate members of the
family, a third hydroxamate moiety is provided by the addition
of fusarinine to rhodotorulic acid to create true coprogen
[Fig. 1(b); Renshaw et al., 2002]. Despite containing a 2,5-
diketopiperazine ring and side-group modifications, coprogens
are linear in structure. Other linear hydroxamate siderophores
include ferrioxamine B and ferrioxamine D, which are
produced by bacteria such as Streptomyces pilosus [Fig. 1(b);
Dhungana et al., 2001; Mu¨ller & Raymond, 1984]. As iron(III)
favours an octahedral coordination geometry, three hydro-
xamate moieties are required to fully coordinate it (Raymond
& Carrano, 1979). Thus, while trihydroxamate coprogens
adopt a 1:1 stoichiometry with iron [Fig. 1(c)], the dihydrox-
amate rhodotorulic acid forms a 3:2 complex of siderophore to
iron at physiological pH and a 1:1 complex at pH < 3 (Carrano
& Raymond, 1978). Diversity between different members of
the coprogen family is provided by the modification of specific
acyl groups to incorporate carboxyl, alkyl and saccharide
moieties (Krasnoff et al., 2014; Renshaw et al., 2002). These
provide the various coprogens with unique chemical proper-
ties that can be selectively recognized by integral membrane
transporters of the ARN/SIT family responsible for coprogen
transport. ARN/SIT transporters belong to a structurally
conserved transporter family with 14 -helical transmembrane
spans and are embedded in the plasma membrane of
coprogen-secreting fungal species (Haas et al., 2008; Dias &
Sa´-Correia, 2013). The selection pressure drives towards a
monopoly of importing the iron-loaded siderophore at the
expense of other organisms (Hibbing et al., 2010; Renshaw et
al., 2002).
When produced in significant quantities, siderophores
provide a further competitive advantage to the secreting
microbe by inhibiting the growth of other organisms by
sequestering environmental iron from them (Winkelmann,
2007; Traxler et al., 2012). In order to counteract this general
strategy and to engage in siderophore piracy, many micro-
organisms possess siderophore transporters not only for the
molecules that they produce but also for those produced by
other microorganisms (Barber & Elde, 2015; Haas et al., 2008).
For example, FhuE is a transporter in Gram-negative bacteria
that can import iron-loaded fungal coprogen (Hantke, 1983).
FhuE belongs to the TonB-dependent transporter (TBDT)
family and has been shown to be both necessary and sufficient
for the utilization of fungally produced coprogens by
Escherichia coli and other Gram-negative bacteria (Sauer et
al., 1990; Bitter et al., 1994; Cui et al., 2006). While the role of
FhuE in coprogen utilization was established some 35 years
ago (Hantke, 1983), the structural and biochemical basis of
how FhuE mediates iron piracy has remained unknown.
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Figure 1
The coprogens: hydroxamate siderophores produced by fungi. (a) Bidentate coordination of Fe3+ by the siderophore catecholate and hydroxamate
functional groups. (b) Hydroxamate siderophores produced by fungi (rhodotorulic acid and coprogen) and bacteria (desferrioxamine B). Hydroxamate
functional groups are highlighted in red, the fusarinine group of coprogen in aqua and the dangling group of desferrioxamine B in green. (c) A two-
dimensional representation of Fe3+ coordination by coprogen.
In this work, we engineered E. coli to require FhuE-
transported substrates as the sole source of iron for growth.
This experimental system demonstrated that while FhuE is
highly efficient in the import of coprogens it is also promis-
cuous, with the ability to import a subset of chemically distinct
hydroxamate siderophores. To determine the structural and
biochemical basis for its selectivity and transport activity, we
solved the crystal structure of FhuE in complex with coprogen.
These data show that FhuE employs a selectivity filter in its
substrate-binding site, making it specific for planar hydro-
xamate siderophores. As the ability to control and sequester
iron is at the heart of microbial competition (Hibbing et al.,
2010), this work provides significant insight into the molecular
mechanisms of microbial iron competition and piracy.
2. Materials and methods
2.1. Engineering of the E. coli DTDBT strain
The E. coli BW25113 TDBT strain was created using
the  Red system (Datsenko & Wanner, 2000). Kanamycin-
resistance cassettes flanked by 300 bp of genomic DNA
corresponding to regions in each of the genes encoding the
TBDTs of interest were amplified using specific mutants from
the E. coli Keio collection (Baba et al., 2006) as templates.
Primers are summarized in Supplementary Table S4.
The host strain E. coli BW25113 was transformed with the
 Red recombinase plasmid pKD46 (Datsenko & Wanner,
2000) and grown at 30C (LB broth + 100 mg ml1 ampicillin)
to an OD600 nm of 0.1 before  Red recombinase was induced
by the addition of 0.2% l-arabinose. The cultures were then
grown at 30C until an OD600 nm of 0.6–0.8 was attained and
were transformed using the room-temperature electropora-
tion method (Tu et al., 2016). Briefly, bacterial cells were
isolated by centrifugation at 3000g for 3 min and washed twice
with a volume of sterile 10% glycerol equal to the volume of
culture used. The cells were then resuspended in 10% glycerol
to a volume of 1/15 of that of the culture. PCR-amplified DNA
(100–500 ng) corresponding to the KanR KO cassette for the
gene of interest was then added to 100 ml of the resuspended
bacteria and the mixture was electroporated. 1 ml of LB broth
was added to the cells post-electroporation, and the culture
was recovered at 37C for 1 h before plating onto LB agar +
30 mg ml1 kanamycin. PCR was used to validate that colonies
did indeed have the KanR cassette in place of the gene of
interest.
To remove the KanR cassette, the mutant strains were
transformed with the plasmid pCP20 (Doublet et al., 2008)
containing the ‘flippase cassette’. Cells were grown under
either ampicillin (100 mg ml1) or chloramphenicol
(30 mg ml1) selection to maintain the plasmid. To remove the
KanR cassette, a single colony of the mutant pCP20-containing
strain was used to inoculate 1 ml LB broth (no selection). The
culture was grown overnight at 43C to activate expression of
the flippase gene. This culture was then subjected to tenfold
serial dilution in sterile LB and plated onto LB agar with no
selection. The resulting colonies were patched onto LB agar
containing kanamycin, chloramphenicol or no selection. PCR
was used to validate that colonies that were unable to grow in
the presence of kanamycin or chloramphenicol, but that grew
in the absence of selection, were successful for removal of the
KanR cassette. This process was repeated sequentially to
derive strains that were multiply defective in up to six TBDT
receptors. The order of deletion was fhuA, fecA, cirA,
fepA, fhuE and then fiu. The mutant strains created in
the process were designated1,2,3,4,5 andTBDT
based on the number of receptors that had been deleted.
2.2. Complementation of E. coli DTBDT with FhuE and
mutant versions of FhuE
The complete open reading frame for FhuE, including the
signal sequence, was amplified from E. coli BW25113 by PCR
(oligonucleotide primer sequences are given in Supplemen-
tary Table S4) and cloned into the plasmid pBAD24 at the
EcoRI and HindIII restriction sites. The resulting vector,
designated pBADFhuECom, was then transformed into the
E. coli BW25113 TBDT strain. The plasmid was maintained
using 100 mg ml1 ampicillin for selection. In order to assess
complementation, E. coli BW25113TBDT pBADFhuECom
was streaked onto LB agar with 0.05% arabinose, 100 mg ml1
ampicillin and 50 mM bipyridine spotted with 2 ml of the
hydroxamate siderophore. Plates were incubated at room
temperature (24C) for 3–7 days and the zone of growth
around the siderophore spot was assessed compared with that
of the control strain E. coli BW25113 TBDT containing the
parent plasmid pBAD24.
To assess the relative importance of the amino acids inter-
acting with coprogen in the crystal structure of FhuE, we
mutated the residues involved in coprogen binding to alanine
using whole-plasmid mutagenesis with pBADFhuECom as the
starting vector (Reikofski & Tao, 1992). Single mutations were
introduced using the oligonucleotide primers in Supplemen-
tary Table S4. The following double mutants were also
generated: R117A/R142A, R117A/W275A and R142A/
W275A. This was achieved through a second round of muta-
genesis of the pBADFhuECom plasmid using the appropriate
primers (Supplementary Table S4). The sequence of the
pBADFhuECom template and the introduction of the speci-
fied mutations in the resultant plasmids were confirmed by
Sanger sequencing. Mutant plasmids were transformed into
the E. coli BW25113 TBDT strain and tested for function as
described for pBADFhuECom.
2.3. Protein expression and purification
For protein production, the FhuE signal sequence was
removed by a cloning strategy using the oligonucleotide
primers outlined in Supplementary Table S4. DNA was
amplified from E. coli BW25113 to incorporate NcoI and XhoI
restriction sites for cloning into a modified pET-20b vector
with an N-terminal 10His tag followed by a TEV cleavage
site. This ligation reaction generated p20bFhuEExp. The
resulting plasmid was transformed into E. coli BL21 (DE3)
C41 cells. After culture in Terrific Broth (12 g tryptone, 24 g
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yeast extract, 12.26 g K2HPO4, 2.31 g KH2PO4 and 4 g glycerol
per litre with 100 mg ml1 ampicillin for plasmid selection) at
37C until an OD600 of 1.0 was reached, protein expression was
induced with 0.3 mM IPTG. The bacteria were cultured for a
further 4–5 h at 37C. Cells were harvested by centrifugation
and lysed using a cell disruptor (Emulsiflex) in lysis buffer
(50 mM Tris, 200 mM NaCl, 2 mM MgCl2) plus 0.1 mg ml
1
lysozyme, 0.05 mg ml1 DNAse I and cOmplete Protease-
Inhibitor Cocktail Inhibitor tablets (Roche). The resulting
lysate was clarified by centrifugation at 10 000g for 10 min and
the supernatant was then centrifuged for 1 h at 160 000g to
isolate a membrane fraction. The supernatant was decanted
and the membrane pellet was suspended in lysis buffer using a
tight-fitting homogenizer. The resuspended membranes were
solubilized by the addition of 10% Elugent (Santa Cruz
Biotechnology) and incubation with gentle stirring at room
temperature for 20 min. The solubilized membrane-protein
fraction was clarified by centrifugation at 20 000g for 10 min.
The supernatant containing the solubilized proteins was
applied onto Ni–agarose resin equilibrated in Ni-binding
buffer [50 mM Tris, 500 mM NaCl, 20 mM imidazole, 0.03%
dodecylmaltoside (DDM) pH 7.9]. The resin was washed with
10–20 column volumes of Ni-binding buffer before elution of
the protein with a step gradient of 10%, 25%, 50% and 100%
Ni-gradient buffer (50 mM Tris, 500 mM NaCl, 1M imidazole,
0.03% DDM pH 7.9). FhuE eluted at the 50% and 100%
gradient steps. Eluted fractions containing FhuE were pooled
and applied onto a 26/600 Superdex S200 size-exclusion
column equilibrated with SEC buffer (50 mM Tris, 200 mM
NaCl, 0.03% DDM pH 7.9). To exchange FhuE into the
detergent octyl -d-glucopyranoside (OG) for crystallo-
graphic and biochemical analysis, fractions containing FhuE
were pooled and applied onto Ni–agarose resin equilibrated in
OG buffer (50 mM Tris, 200 mM NaCl, 0.8% OG pH 7.9).
The resin was washed with ten column volumes of OG buffer
before elution with OG buffer plus 250 mM imidazole.
Fractions containing FhuE were pooled, and 6His-tagged
TEV protease (final concentration 1 mg ml1) and DTT (final
concentration 1 mM) were added. This solution was then
dialyzed against OG buffer for 4–6 h at 20C to allow TEV
cleavage of the 10His tag from FhuE and the removal of
excess imidazole. The sample was then applied onto Ni–
agarose resin to remove TEV protease and the cleaved
decahistidine peptide. The flowthrough containing FhuE from
this step was collected, concentrated to 10 mg ml1 in a
30 kDa cutoff centrifugal concentrator, snap-frozen and
stored at 80C.
For control experiments, Fiu was cloned, expressed and
purified using the same method as described for FhuE (the
primers are listed in Supplementary Table S4).
2.4. FhuE substrate-binding analysis by tryptophan
fluorescence quenching
Purified FhuE or Fiu was diluted to 300 nM in DDM buffer
(50 mM Tris, 200 mM NaCl, 0.03% DDM pH 7.9) and
incubated with hydroxamate siderophores (0–200 mM): Fe-
coprogen, Fe-rhodotorulic acid, ferrioxamine B, ferrioxamine
E and ferrichrome (obtained from EMC microcollections or
from Sigma). The fluorescence of the resulting solutions was
measured at 330 and 350 nM using a Prometheus NT.48 DSF
(NanoTemper) to determine the quenching of binding-site
tryptophan residues at a given ligand concentration. Each
titration series was performed in triplicate and averaged, with
the normalized fluorescence intensity plotted for each
compound to obtain substrate-binding curves. Raw data were
normalized using the formula F0/F F0, where F0 is the initial
fluorescence in the absence of substrate and F is the fluores-
cence observed at a given concentration of ligand.
Thermal stabilization of FhuE in the presence of hydro-
xamate siderophores was also measured using the Prometheus
NT.48 DSF. Thermal melting was performed from 20 to 90C
for FhuE in the presence of siderophores at the concentrations
listed above.
2.5. Protein crystallization, data collection and structure
solution
Purified FhuE in OG buffer was screened for crystal-
lization in the presence and absence of its substrate coprogen
using commercially available crystallization screens (approxi-
mately 600 conditions). For co-crystallization, coprogen (EMC
microcollections) was added to purified FhuE, giving final
concentrations of 1.25 mM coprogen and 100 mM FhuE
(8 mg ml1).
Crystals formed in numerous conditions in the presence of
coprogen, and also in some conditions in the absence of
coprogen. Crystals that formed in the presence of coprogen
were slightly orange in colour, consistent with the formation
of the FhuE–coprogen complex in crystallo. A number of
conditions were selected for optimization screens; however,
these crystals suffered from poor morphology and crystals
were therefore harvested directly from the screening trays.
Crystals were looped, excess mother liquor was removed by
wicking and crystals were flash-cooled to 100 K in liquid N2.
Crystals were screened for diffraction on the MX2 beamline at
the Australian Synchrotron.
Crystals in the absence of coprogen diffracted poorly.
However, crystals in the presence of coprogen from a number
of conditions diffracted to better than 3 A˚ resolution. The best
diffracting crystal came from the PACT screen and was grown
in 0.1M PCB pH 4 (buffer), 25%(w/v) PEG 1500 (Newman et
al., 2005). This crystal suffered from significant anisotropy but
diffracted to at least 2 A˚ resolution along the a* and b* axes.
Multiple wedges of data were collected from different sites of
this crystal, processed with XDS, scaled using XSCALE and
merged with AIMLESS from the CCP4 package (Kabsch,
2010; Winn et al., 2011); data were collected to a maximum
resolution of 2.00 A˚ at the detector edge and the resolution
was limited to 2.00 A˚ during processing. Data output from
XSCALE were elliptically truncated and scaled aniso-
tropically using the Diffraction Anisotropy Server (Strong et
al., 2006). Reflections in outer resolution shells with an F/ of
<3.0 (the average F/ of discarded reflections was 2.55) were
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discarded, leading to resolution limits of 2.00, 2.10 and 3.20 A˚
along a*, b* and c*, respectively. Anisotropic scale factors
were then applied to the data set, followed by an isotropic B
factor of 41.78 A˚2. The crystal structure was solved in space
group P212121 by molecular replacement with Phaser (McCoy
et al., 2007) using a model derived from the TDBT FauA from
Bordetella pertussis (PDB entry 3efm; 37% amino-acid iden-
tity; Brillet et al., 2009) . The model was built and refined using
phenix.refine from the PHENIX package, AutoBUSTER and
Coot (Adams et al., 2010; Emsley et al., 2010; Bricogne et al.,
2019). The entire FhuE polypeptide chain was modelled into
the available density, with clear electron density for coprogen
observed in the extracellular cavity of FhuE. The quality of
the refined FhuE–coprogen crystal structure was validated
using the MolProbity web server (Chen et al., 2010). For
generation of the composite OMIT map, the ‘composite omit
map’ tool from the PHENIX package was used (Adams et al.,
2010). Maps were calculated using model phases of FhuE built
and refined before coprogen was modelled to ensure that
there was no residual model bias.
2.6. In silico docking
In order to determine potential ligand-binding sites in the
crystal structure of FhuE, an in silico docking approach was
applied using AutoDock Vina via the command line and
within the UCSF Chimera software package (Pettersen et al.,
2004; Trott & Olson, 2010). The coordinates for ferrioxamine
B were obtained from the Cambridge Crystallographic Data
Centre (accession code OFUYET; Dhungana et al., 2001).
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Figure 2
The ability of FhuE to utilize hydroxamate siderophores correlates with in vitro binding affinity. (a) A solid agar growth assay of the E. coli strain lacking
other high-affinity uptake systems (E. coli TBDT; see Section 2), illustrating FhuE-dependent growth using either coprogen, rhodotorulic acid or
ferrioxamine B as an exclusive source of iron. Plates were spotted with the siderophore solution and the growth of bacteria expressing FhuE (+pFhuE)
or not (+pBAD24) was assessed after incubation for 72 h at 24C. (b) Plot of normalized fluorescence quenching of FhuE at 330 nm at increasing
concentrations of siderophore. For Fe-coprogen and Fe-rhodotorulic acid, the observed change in fluorescence is attributable to the quenching of
tryptophan residues in the FhuE substrate-binding pocket owing to siderophore binding. F0, fluorescence at 0 mM substrate concentration; F,
fluorescence at the listed substrate concentration. Error bars are derived from the standard deviation of three independent experiments.
Coordinates for Fe-rhodotorulic acid in a 3:2 complex with
iron in configurations 1 and 2 were built manually in PyMOL
and UCSF Chimera before being subjected to energy-
minimization refinement and regularization using the UCSF
Chimera package (Pettersen et al., 2004). A box size of 46.5 
56.0  45.5 A˚ was utilized encompassing the entire extra-
cellular portion of FhuE. A total of 9–10 binding modes were
sought for each docking run, with a search exhaustiveness of
8–100 and a maximum energy differ-
ence of 3 kcal mol1. Docking solutions
were visually inspected and the highest
rated solution was used for the main
figures and for discussions.
3. Results
3.1. FhuE utilizes Fe-coprogen as a
high-affinity substrate
Previous reports on FhuE (Hantke,
1983; Matzanke et al., 1984) suggested
that it can import three linear hydro-
xamate siderophores, coprogen, rhodo-
torulic acid and ferrioxamine B (Fig. 1),
but not the cyclic siderophores ferriox-
amine E or ferrichrome. However, the
relative affinity of FhuE for these
substrates was unclear. Measuring the
specificity of FhuE for these substrates
in vivo required a genetically modified
biological system. To this end, we engi-
neered a strain of E. coli BW25113 that
lacks all of the TBDTs involved in iron
acquisition (designated TBDT;
Section 2). This bacterial strain grows
very poorly on solid media without the
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Figure 3
The crystal structure of FhuE in complex with
coprogen reveals a substrate-binding site
selective for planar hydroxamate siderophores.
(a) Structure of FhuE coloured as a Jones’
rainbow from the N-terminus (blue) to the
C-terminus (red). The transmembrane region is
indicated as being within the outer membrane
(OM), and extracellular loops are labelled
from L1 to L11. Transposed by 90, the lower
panel shows a top-down view of FhuE. (b) Fe-
coprogen co-crystallized with FhuE is shown
bound to the substrate-binding pocket as a red
stick model, with FhuE as a blue cartoon (top),
key interacting residues as blue sticks (middle)
and a white surface representation (bottom).
Models of Fe-rhodotorulic acid (c) and ferriox-
amine B (d) in complex with FhuE derived
from in silico docking are shown with FhuE as a
white surface representation. (e) The location
of the coprogen trans-anhydromevalonyl group
in the substrate-binding tunnel of FhuE and the
dangling group of ferrioxamine B docked in an
analogous position. ( f ) The role of Arg142 in
restricting the FhuE binding pocket to planar
hydroxamate siderophores. Planar Fe-
coprogen is accommodated in the FhuE
binding site (left), while the nonplanar sidero-
phore ferrichrome is sterically excluded by
Arg142 (right).
addition of exogenous iron [Fig. 2(a)]. Transforming the
TBDT strain with a plasmid to drive the expression of FhuE
supported growth on media containing coprogen, rhodotorulic
acid or ferrioxamine B as an iron source, but not those with
ferrichrome or ferrioxamine E [Fig. 2(a), Supplementary Fig.
S1(a)]. Of the three siderophores that supported growth,
the extent of growth enhancement differed markedly. Fe-
coprogen supported a large zone of growth, Fe-rhodotorulic
acid a slightly smaller zone and ferrioxamine B a compara-
tively small zone, suggesting lower efficiency in the import of
the two latter substrates [Fig. 2(a)]. To test this proposition,
FhuE was purified and tryptophan fluorescence quenching
was used to directly measure its affinity for the siderophores.
Quenching of FhuE fluorescence was observed upon titration
of all five siderophores. For Fe-coprogen and Fe-rhodotorulic
acid this decrease in fluorescence was titratable, giving dis-
association constants of 508  116 nM for Fe-coprogen and 30
 14 mM for Fe-rhodotorulic acid [Fig. 2(b)].
For ferrioxamine B, ferrioxamine E and ferrichrome the
degree of observed quenching was variable and did not satu-
rate at a ligand concentration of up to 200 mM [Fig. 2(b),
Supplementary Fig. S1(b)]. To differentiate tryptophan fluor-
escence quenching owing to substrate binding from non-
specific quenching at high concentrations of substrate, we
performed a control experiment with purified Fiu, a non-
hydroxamate siderophore receptor, in place of FhuE (Nikaido
& Rosenberg, 1990). For these three siderophores the
magnitude of the quenching observed for Fiu was similar to
that for FhuE [Supplementary Figs. S1(a) and S2], suggesting
that the majority of the quenching observed for these
compounds is nonspecific and they are bound very weakly by
FhuE, if at all. For Fe-coprogen and Fe-rhodotorulic acid this
nonspecific quenching was negligible (Supplementary Fig. S2).
For a further independent assessment of its interaction with
these siderophores, FhuE was subjected to thermal melting
in the presence of various concentrations of substrate. In
agreement with the substrate-binding assays and substrate-
dependent growth assays, Fe-coprogen and Fe-rhodotorulic
acid stabilized FhuE, while ferrioxamine B, ferrichrome and
ferrioxamine E did not. Coprogen exhibited the strongest shift
in melting temperature: from 69.8 to 72.5C. As expected, Fiu
was not stabilized by any of the siderophores (Supplementary
Fig. S3).
Taken together, these data show that while FhuE is capable
of binding and transporting Fe-coprogen, Fe-rhodotorulic acid
and ferrioxamine B, there is a large difference in substrate
affinity and transport efficiency.
3.2. The crystal structure of FhuE reveals selectivity for
planar siderophores
To determine the molecular basis for the transport of both
high-affinity and low-affinity substrates by FhuE, we solved
the crystal structure of FhuE in complex with Fe-coprogen
(Supplementary Table S1). The structure of FhuE consists of a
canonical TBDT fold (Noinaj et al., 2010) consisting of a
22-stranded transmembrane -barrel, the lumen of which is
occluded by a globular plug domain [Fig. 3(a)]. Comparison of
FhuE to other structures in the PDB using the DALI server
(Holm & Laakso, 2016) revealed that it is structurally most
similar to the ferripyoverdine receptor FpvAI (PDB entry
2iah; Z-score of 43.7; r.m.s.d. of 2.0 A˚; C. Wirth, W. Meyer-
Klaucke, F. Pattus & D. Cobessi, unpublished work) from the
bacterium Pseudomonas aeruginosa (Supplementary Table
S2). FhuE shares a relatively modest 36% amino-acid identity
with FpvAI. Pyoverdine, the substrate of FpvAI, is a mixed-
ligand siderophore that is widely produced by Pseudomonas
spp. and is structurally unrelated to coprogen [Supplementary
Fig. S4(a); Cobessi et al., 2005]. The most parsimonious
explanation for the observed structural homology between
these two relatively distantly related transporters is that they
originated from a common ancestor and have evolved to bind
distinct iron-loaded substrates.
Electron density attributable to coprogen in complex with a
single Fe ion was present in an internal cavity in the surface of
FhuE, into which Fe-coprogen was modelled [Supplementary
Fig. S5(a), Supplementary Data]. Coprogen sits in a semi-
enclosed binding pocket coordinated by a combination of
aromatic, polar and charged residues [Fig. 3(b)]. Notably, all
three hydroxamate groups of coprogen are coordinated by
FhuE through two arginine residues (Arg117 and Arg142) and
a tryptophan residue (Trp275). An additional hydrogen bond
is observed between one of the keto O atoms of the coprogen
diketopiperazine ring and an asparagine residue (Asn373),
with the remainder of the binding pocket being composed of
hydrophobic interactions [Fig. 3(b), Supplementary Fig. S5(b)
and Supplementary Movie S1]. Interestingly, comparative
analysis of the structure of FpvAI in complex with pyoverdine
revealed that the substrate-binding site, as judged by the
location of the coordinated Fe atom, is conserved between
FhuE and FpvAI. Residues equivalent to Arg117 and Trp275
were also conserved in FpvAI, where they form interactions
with Fe-coordinating pyoverdine functional groups. However,
the other residues involved in substrate interactions and the
overall shape of the binding pockets are distinct [Supple-
mentary Figs. S4(b) and S4(c)].
In order to determine the binding mode for the low-affinity
FhuE substrates Fe-rhodotorulic acid and ferrioxamine B, we
performed in silico docking with the FhuE crystal structure
(Supplementary Table S3; Dhungana et al., 2001). Previous
work showed that at physiological pH rhodotorulic acid
adopts a 3:2 complex with iron (Carrano & Raymond, 1978).
In this work, the authors proposed a model for this complex in
which three rhodotorulic acid molecules bridge between two
Fe ions to form a complex with threefold pseudosymmetry
[Supplementary Fig. S6(a)]. However, this complex coordi-
nates Fe in a nonplanar configuration which appears to be
incompatible with the FhuE substrate-binding site. In order to
satisfy the observed 3:2 stoichiometry, an alternative possibi-
lity exists in which each Fe atom is coordinated by two
hydroxamate groups from a single rhodotorulic acid molecule,
with the third rhodotorulic acid molecule bridging two of these
complexes through a single interaction with each Fe atom
[Supplementary Fig. S6(b)]. As the structure of Fe-rhodotorulic
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acid has not been determined experimentally, we prepared
models of each of these two possible configurations and
performed docking with FhuE. Fe-rhodotorulic acid in
configuration 1 did not dock into the substrate-binding site
identified in the FhuE–coprogen crystal structure [Supple-
mentary Fig. S6(c)]. However, configuration 2 docked with the
FhuE substrate-binding site with one rhodotorulic acid
molecule from the complex in an analogous position to Fe-
coprogen, with the coordinated Fe atoms within 0.4 A˚
[Fig. 3(c), Supplementary Fig. S6(a), Supplementary Data].
This result suggests that FhuE is most suited to binding
configuration 2 of the Fe-rhodotorulic acid complex. However,
we cannot preclude the possibility that flexibility in the FhuE
binding site allows accommodation of the originally proposed
conformation 1 (Carrano & Raymond, 1978). Further
experimental evidence is required to determine the nature of
iron coordination by this siderophore.
For ferrioxamine B the most favoured docking solution also
placed this molecule in an analogous position to that of Fe-
coprogen. The Fe atoms in the complexes are within 0.2 A˚,
and the loops formed through the
coordination of iron are in a similar
planar orientation [Fig. 3(d)]. The
dangling chain of ferrioxamine B, which
terminates in an amine group, pene-
trates a narrow cavity in the FhuE
binding pocket [Fig. 1(b)]. In the crystal
structure this cavity accommodates
the trans-anhydromevalonyl group of
coprogen in the analogous position
[Fig. 3(e)]. This docking result suggests
that the binding mode between Fe-
coprogen and ferrioxamine B is analo-
gous, raising the prospect that the large
difference in affinity observed between
the two molecules can be attributed to
tailoring of the FhuE binding pocket to
Fe-coprogen through the course of
evolution.
The crystal structure of FhuE also
provides an explanation as to why it is
unable to utilize the trihydroxamate
siderophore ferrichrome as a substrate
(Hantke, 1983). The planar nature of
the FhuE binding pocket does not allow
the coordination of the Fe-ferrichrome
complex without significant clashes. The
direct coordination via Arg142 of the
hydroxamate groups appears to act as a
selectivity filter, only allowing Fe-
hydroxamate complexes in a planar
configuration to be accommodated in
the substrate-binding pocket [Figs. 3(b),
3(c) and 3(d)]. Superimposition of the
nonplanar ferrichrome with coprogen
shows significant clashes with Arg142
[Fig. 3(e), Supplementary Movie S2].
3.3. Functional mutagenesis of FhuE
shows that hydroxamate coordination
is crucial for substrate import
To address the role of the amino acids
that constitute the FhuE substrate-
binding pocket, we mutated all residues
directly involved in coordinating Fe-
coprogen to alanine [Fig. 4(a)]. The
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Figure 4
Mutagenesis of the FhuE substrate-binding site reveals residues that are key for receptor function
and selectivity. (a) A cross-eyed stereo representation of the FhuE substrate-binding site containing
Fe-coprogen. Residues involved in coprogen coordination that were subjected to mutagenesis are
shown as blue sticks, coprogen is shown as a red wire and Fe is shown as an orange sphere.
Interactions between FhuE and coprogen of <3.5 A˚ are labelled. (b) The effect of mutations of
FhuE on its ability to utilize the siderophores as an iron source to support the growth of E. coli
TBDT on solid agar. Growth differences were scored by observing the size of growth around a
spot of siderophore compared with that of wild-type FhuE. The growth of the N373A mutant with
ferrioxamine B as a substrate is highlighted; using this substrate, the growth of the N373A mutant
exceeded that of wild-type FhuE.
E. coli TBDT strain was used to express these mutant
variants of FhuE, and the ability of the FhuE variants to
support growth at varying siderophore concentrations was
assessed [Fig. 4(b), Supplementary Fig. S7]. Double mutants
were also constructed for R117A, R142A and W275A that
directly coordinate the hydroxamate moieties of Fe-coprogen.
All of the mutants were then scored for fitness compared with
the strain expressing ‘wild-type’ FhuE.
Each of the single mutations yielded a relatively minor
effect on the ability of FhuE to utilize coprogen, but all double
mutants were impaired in their activity, with the R117A/
W275A mutant being totally nonfunctional [Fig. 4(b),
Supplementary Fig. S7]. It is possible that expression levels
differ between mutant and wild-type FhuE, leading to a
difference in the growth phenotype in this assay. However,
none of the amino acids that were mutated play a structural
role in FhuE and the TBDT fold is highly stable, making it less
likely that these mutations would have a major effect on FhuE
expression. Based on this assumption, these data show that the
enclosed binding site of FhuE and the large number of resi-
dues involved in coordinating Fe-coprogen mean that any
individual mutation of the binding site can be tolerated.
However, the mutation of multiple residues interacting with
the iron-loaded coprogen is deleterious for substrate acquisi-
tion. Interestingly, while Trp275 and Arg117 are crucial for Fe-
coprogen utilization, Arg142 apparently plays a more minor
role in the process. This supports the notion of a distinct role
for Arg142 in substrate selection by defining the planar FhuE
binding pocket.
A distinct situation was in evidence when assessing the role
of mutant variants of FhuE in utilizing Fe-rhodotorulic acid as
a substrate. Single mutations had a more major effect, with the
W143A and W275A mutants and the R117A/R142A double
mutant failing to grow on Fe-rhodotorulic acid as an iron
source and with the R117A, Y341A and N373A mutants
leading to a pronounced reduction in substrate utilization
[Fig. 4(b), Supplementary Fig. S7]. Thus, while the same set of
residues do provide for utilization of iron-loaded coprogen for
cell growth, rhodotorulic acid utilization is selectively defec-
tive. We suggest that this is likely to reflect the smaller number
of binding-site residues involved
in interaction with this substrate
[Fig. 3(c)] and the observed
weaker binding affinity [Fig. 2(b)].
As expected, the residues Ser141,
Asn303, Ser337 and Asp343 in
the binding site that form inter-
actions with Fe-coprogen but are
unlikely to coordinate Fe-rhodo-
torulic acid did not affect the
function of FhuE with this
substrate (Supplementary Movie
S3).
3.4. Mutation of Asn373 to
alanine in FhuE leads to
enhanced ferrioxamine B import
The majority of the mutations
had a severe effect on the ability
of FhuE to utilize ferrioxamine B
as an iron source [Fig. 4(b),
Supplementary Movie S3], with
only S141A, N373A and W416A
mutants permitting significant
FhuE-mediated growth using
ferrioxamine B. This observation
is consistent with the very weak
binding observed between FhuE
and ferrioxamine B [Fig. 2(b)].
Strikingly, rather than decreasing
the ability of FhuE to utilize
ferrioxamine, the N373A muta-
tion led to a significant increase in
growth [Fig. 5(a), Supplementary
Figure S7]. Analysis of the struc-
ture of FhuE with docked
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Figure 5
Mutation of Asn373 enhances the ability of FhuE to utilize ferrioxamine B. (a) A solid agar growth assay
showing the enhanced ability of the N373A mutant to support growth using ferrioxamine B as an iron
source relative to the growth observed in the presence of FhuE. (b) Structural modelling of the N373A
mutant with ferrioxamine B docked into the substrate-binding pocket. The removal of the asparagine side
chain opens the substrate-binding channel of FhuE to better accommodate ferrioxamine B. (c) The position
of Asn373 (blue sticks) relative to coprogen (left) and ferrioxamine B (right). In the crystal structure,
Asn373 forms a hydrogen bond to a carbonyl group from the coprogen diketopiperazine ring. This group is
not present in ferrioxamine B.
ferrioxamine B provides a molecular basis for this improved
utilization: Asn373 forms one side of the channel entrance in
FhuE, with the N373A mutation opening up this region, better
accommodating the dangling chain of ferrioxamine B
[Figs. 5(b) and 5(c), Supplementary Movie S4]. This experi-
mental system thereby provides insight into how the random
acquisition of mutations in nature could allow the modifica-
tion of FhuE substrate specificity. Mutations of this kind could
represent evolutionary tinkering, allowing bacteria to evolve
transporters with novel substrate specificity, as indicated by
the structural relationships observed between FhuE and the
ferripyoverdine receptor FpvAI from the bacterium
P. aeruginosa (Supplementary Table S1 and Fig. S4).
4. Discussion
Biologically available iron is a limiting resource in poly-
microbial communities. There is a growing awareness that
some bacteria employ a ‘Black Queen’ strategy in which they
utilize resources produced by the community rather than
producing their own. This strategy leads to the loss of genes
encoding the production of these resources and to the reliance
on other community members to satisfy their requirements
(Morris et al., 2012). Applying this strategy, bacteria utilize
iron sequestered in siderophores made by other members of
the community as their source of this nutrient rather than
producing their own siderophores (Ratledge & Dover, 2000;
Morris, 2015). The high affinity and selectivity of FhuE for
coprogen siderophores that we report in this study provides an
advantage to the producing bacteria. In a mixed microbial
community FhuE would allow the producing bacteria to
acquire iron sequestered in these fungal siderophores at a far
lower selective cost than producing their own (Khan et al.,
2006; Hibbing et al., 2010).
This lower cost of siderophore ‘piracy’ explains the exis-
tence of FhuE, but does not explain its observed specificity for
coprogen and other planar siderophores. Why did FhuE not
evolve a substrate-binding site that could accommodate both
planar and nonplanar hydroxamate siderophores? This
strategy is adopted by the periplasmic siderophore-binding
protein FhuD: this soluble protein acts downstream of TBDTs
and binds diverse hydroxamate siderophores including Fe-
coprogen, ferrioxamine B and ferrichrome. FhuD mediates
this generalist binding through an open binding pocket, which
interacts with its siderophore binding partner via direct
interactions with the hydroxamate–iron complex (Supple-
mentary Fig. S8, Supplementary Movie S5; Clarke et al., 2002).
In part, this question is answered by the need to ensure
sufficiently high-affinity binding to Fe-coprogen to compete
effectively against the siderophore-producing species.
However, nutritional need is not the only evolutionary force at
play in microbial communities. In addition to their function
in siderophore import, TBDTs are also the target of anti-
microbial toxins. Such molecules are composed of an anti-
biotic activity fused to a siderophore, or molecules that have
evolved to mimic the TBDT substrate (Go´rska et al., 2014;
Ferguson et al., 2001; Grinter et al., 2014, 2016). An example of
the former is albomycin, an antibiotic ferrichrome fusion that
binds to, and is imported by, the ferrichrome transporter FhuA
(Ferguson et al., 2000). Under conditions in which albomycin
is present, FhuA represents a liability to the bacterium. The
specificity of FhuE for planar siderophores excludes not only
ferrichrome, as we demonstrate in this study, but also ferri-
chrome–antibiotic fusions such as albomycin. In a scenario
where albomycin is present, the exclusion of nonplanar sidero-
phores by FhuE prevents antibiotic import, while allowing
FhuE to continue to function in iron acquisition via Fe-
coprogen. Understood from this perspective, the lack of a
single generic receptor for hydroxamate siderophore import in
Gram-negative bacteria makes sense; it represents an evolu-
tionary bet-hedging strategy, which counteracts the targeting
of TBDTs by antimicrobial siderophore mimics.
While FhuE can import ferrioxamine B, it has a low affinity
for the substrate and it therefore provides a relatively modest
level of growth. However, we show that the mutation N373A
in FhuE enhances its ability to import ferrioxamine B. This
mutation would provide a clear advantage to bacteria growing
in a community where ferrioxamine B was present by
increasing their ability to utilize this siderophore as an iron
source. In this scenario, if the presence of ferrioxamine B was
sustained it would lead to the selection of additional mutations
in FhuE that enhance the utilization of this substrate, and over
time to a receptor with a new specificity range. These evolu-
tionary forces are likely to be echoed in the observed simila-
rities between the substrate-binding sites of FhuE and FpvAI,
which share key binding residues despite the fact they trans-
port highly structurally distinct substrates (Schauer et al.,
2008). TBDTs share a common fold and a deep evolutionary
history, but have diverged radically in their amino-acid
compositions and have evolved distinct binding sites to target
different substrates. This process, which is observed in
miniature in this work, has allowed bacterial species to cope
with new ecological challenges.
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